KDM1A and non-small cell lung carcinoma: The combined treatment of NSCLC cells with SP2509 LSD1 inhibitor and siRNA against TdIF1 synergistically led to reverting the cadherin switch, causing the upregulation of the expression of E-cadherin and downregulation of N-cadherin, which were associated with diminished cell invasion [38].